Global Alpha Thalassemia Market Size, Status and Forecast 2020-2026

May 2020 | 91 pages | ID: GFDDFE009931EN
QYResearch

Abstracts

This report focuses on the global Alpha Thalassemia status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Alpha Thalassemia development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Bluebird Bio
• Novartis
• Kiadis Pharma
• Acceleron Pharma
• ...

Market segment by Type, the product can be split into

• Iron Chelating Drugs
• Gene Therapy

Market segment by Application, split into

• Hospitals
• Private clinics
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Alpha Thalassemia status, future forecast, growth opportunity, key market and key players.
• To present the Alpha Thalassemia development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Alpha Thalassemia are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Alpha Thalassemia Revenue
1.4 Market Analysis by Type
  1.4.1 Global Alpha Thalassemia Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Iron Chelating Drugs
  1.4.3 Gene Therapy
1.5 Market by Application
  1.5.1 Global Alpha Thalassemia Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Private clinics
  1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Alpha Thalassemia Market Perspective (2015-2026)
2.2 Alpha Thalassemia Growth Trends by Regions
  2.2.1 Alpha Thalassemia Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Alpha Thalassemia Historic Market Share by Regions (2015-2020)
  2.2.3 Alpha Thalassemia Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Alpha Thalassemia Market Growth Strategy
  2.3.6 Primary Interviews with Key Alpha Thalassemia Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Alpha Thalassemia Players by Market Size
  3.1.1 Global Top Alpha Thalassemia Players by Revenue (2015-2020)
  3.1.2 Global Alpha Thalassemia Revenue Market Share by Players (2015-2020)
  3.1.3 Global Alpha Thalassemia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Alpha Thalassemia Market Concentration Ratio
  3.2.1 Global Alpha Thalassemia Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Alpha Thalassemia Revenue in 2019
3.3 Alpha Thalassemia Key Players Head office and Area Served
3.4 Key Players Alpha Thalassemia Product Solution and Service
3.5 Date of Enter into Alpha Thalassemia Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Alpha Thalassemia Historic Market Size by Type (2015-2020)
4.2 Global Alpha Thalassemia Forecasted Market Size by Type (2021-2026)

5 ALPHA THALASSEMIA BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Alpha Thalassemia Market Size by Application (2015-2020)
5.2 Global Alpha Thalassemia Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Alpha Thalassemia Market Size (2015-2020)
6.2 Alpha Thalassemia Key Players in North America (2019-2020)
6.3 North America Alpha Thalassemia Market Size by Type (2015-2020)
6.4 North America Alpha Thalassemia Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Alpha Thalassemia Market Size (2015-2020)
7.2 Alpha Thalassemia Key Players in Europe (2019-2020)
7.3 Europe Alpha Thalassemia Market Size by Type (2015-2020)
7.4 Europe Alpha Thalassemia Market Size by Application (2015-2020)

8 CHINA

8.1 China Alpha Thalassemia Market Size (2015-2020)
8.2 Alpha Thalassemia Key Players in China (2019-2020)
8.3 China Alpha Thalassemia Market Size by Type (2015-2020)
8.4 China Alpha Thalassemia Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Alpha Thalassemia Market Size (2015-2020)
9.2 Alpha Thalassemia Key Players in Japan (2019-2020)
9.3 Japan Alpha Thalassemia Market Size by Type (2015-2020)
9.4 Japan Alpha Thalassemia Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Alpha Thalassemia Market Size (2015-2020)
10.2 Alpha Thalassemia Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Alpha Thalassemia Market Size by Type (2015-2020)
10.4 Southeast Asia Alpha Thalassemia Market Size by Application (2015-2020)

11 INDIA

11.1 India Alpha Thalassemia Market Size (2015-2020)
11.2 Alpha Thalassemia Key Players in India (2019-2020)
11.3 India Alpha Thalassemia Market Size by Type (2015-2020)
11.4 India Alpha Thalassemia Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Alpha Thalassemia Market Size (2015-2020)
12.2 Alpha Thalassemia Key Players in Central & South America (2019-2020)
12.3 Central & South America Alpha Thalassemia Market Size by Type (2015-2020)
12.4 Central & South America Alpha Thalassemia Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Bluebird Bio
  13.1.1 Bluebird Bio Company Details
  13.1.2 Bluebird Bio Business Overview and Its Total Revenue
  13.1.3 Bluebird Bio Alpha Thalassemia Introduction
  13.1.4 Bluebird Bio Revenue in Alpha Thalassemia Business (2015-2020))
  13.1.5 Bluebird Bio Recent Development
13.2 Novartis
  13.2.1 Novartis Company Details
  13.2.2 Novartis Business Overview and Its Total Revenue
  13.2.3 Novartis Alpha Thalassemia Introduction
  13.2.4 Novartis Revenue in Alpha Thalassemia Business (2015-2020)
  13.2.5 Novartis Recent Development
13.3 Kiadis Pharma
  13.3.1 Kiadis Pharma Company Details
  13.3.2 Kiadis Pharma Business Overview and Its Total Revenue
  13.3.3 Kiadis Pharma Alpha Thalassemia Introduction
  13.3.4 Kiadis Pharma Revenue in Alpha Thalassemia Business (2015-2020)
  13.3.5 Kiadis Pharma Recent Development
13.4 Acceleron Pharma
  13.4.1 Acceleron Pharma Company Details
  13.4.2 Acceleron Pharma Business Overview and Its Total Revenue
  13.4.3 Acceleron Pharma Alpha Thalassemia Introduction
  13.4.4 Acceleron Pharma Revenue in Alpha Thalassemia Business (2015-2020)
  13.4.5 Acceleron Pharma Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Alpha Thalassemia Key Market Segments
Table 2. Key Players Covered: Ranking by Alpha Thalassemia Revenue
Table 3. Ranking of Global Top Alpha Thalassemia Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Alpha Thalassemia Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Iron Chelating Drugs
Table 6. Key Players of Gene Therapy
Table 7. Global Alpha Thalassemia Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Alpha Thalassemia Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Alpha Thalassemia Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Alpha Thalassemia Market Share by Regions (2015-2020)
Table 11. Global Alpha Thalassemia Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Alpha Thalassemia Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Alpha Thalassemia Market Growth Strategy
Table 17. Main Points Interviewed from Key Alpha Thalassemia Players
Table 18. Global Alpha Thalassemia Revenue by Players (2015-2020) (Million US$)
Table 19. Global Alpha Thalassemia Market Share by Players (2015-2020)
Table 20. Global Top Alpha Thalassemia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alpha Thalassemia as of 2019)
Table 21. Global Alpha Thalassemia by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Alpha Thalassemia Product Solution and Service
Table 24. Date of Enter into Alpha Thalassemia Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Alpha Thalassemia Market Size by Type (2015-2020) (Million US$)
Table 27. Global Alpha Thalassemia Market Size Share by Type (2015-2020)
Table 28. Global Alpha Thalassemia Revenue Market Share by Type (2021-2026)
Table 29. Global Alpha Thalassemia Market Size Share by Application (2015-2020)
Table 30. Global Alpha Thalassemia Market Size by Application (2015-2020) (Million US$)
Table 31. Global Alpha Thalassemia Market Size Share by Application (2021-2026)
Table 32. North America Key Players Alpha Thalassemia Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Alpha Thalassemia Market Share (2019-2020)
Table 34. North America Alpha Thalassemia Market Size by Type (2015-2020) (Million US$)
Table 35. North America Alpha Thalassemia Market Share by Type (2015-2020)
Table 36. North America Alpha Thalassemia Market Size by Application (2015-2020) (Million US$)
Table 37. North America Alpha Thalassemia Market Share by Application (2015-2020)
Table 38. Europe Key Players Alpha Thalassemia Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Alpha Thalassemia Market Share (2019-2020)
Table 40. Europe Alpha Thalassemia Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Alpha Thalassemia Market Share by Type (2015-2020)
Table 42. Europe Alpha Thalassemia Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Alpha Thalassemia Market Share by Application (2015-2020)
Table 44. China Key Players Alpha Thalassemia Revenue (2019-2020) (Million US$)
Table 45. China Key Players Alpha Thalassemia Market Share (2019-2020)
Table 46. China Alpha Thalassemia Market Size by Type (2015-2020) (Million US$)
Table 47. China Alpha Thalassemia Market Share by Type (2015-2020)
Table 48. China Alpha Thalassemia Market Size by Application (2015-2020) (Million US$)
Table 49. China Alpha Thalassemia Market Share by Application (2015-2020)
Table 50. Japan Key Players Alpha Thalassemia Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Alpha Thalassemia Market Share (2019-2020)
Table 52. Japan Alpha Thalassemia Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Alpha Thalassemia Market Share by Type (2015-2020)
Table 54. Japan Alpha Thalassemia Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Alpha Thalassemia Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Alpha Thalassemia Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Alpha Thalassemia Market Share (2019-2020)
Table 58. Southeast Asia Alpha Thalassemia Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Alpha Thalassemia Market Share by Type (2015-2020)
Table 60. Southeast Asia Alpha Thalassemia Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Alpha Thalassemia Market Share by Application (2015-2020)
Table 62. India Key Players Alpha Thalassemia Revenue (2019-2020) (Million US$)
Table 63. India Key Players Alpha Thalassemia Market Share (2019-2020)
Table 64. India Alpha Thalassemia Market Size by Type (2015-2020) (Million US$)
Table 65. India Alpha Thalassemia Market Share by Type (2015-2020)
Table 66. India Alpha Thalassemia Market Size by Application (2015-2020) (Million US$)
Table 67. India Alpha Thalassemia Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Alpha Thalassemia Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Alpha Thalassemia Market Share (2019-2020)
Table 70. Central & South America Alpha Thalassemia Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Alpha Thalassemia Market Share by Type (2015-2020)
Table 72. Central & South America Alpha Thalassemia Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Alpha Thalassemia Market Share by Application (2015-2020)
Table 74. Bluebird Bio Company Details
Table 75. Bluebird Bio Business Overview
Table 76. Bluebird Bio Product
Table 77. Bluebird Bio Revenue in Alpha Thalassemia Business (2015-2020) (Million US$)
Table 78. Bluebird Bio Recent Development
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Product
Table 82. Novartis Revenue in Alpha Thalassemia Business (2015-2020) (Million US$)
Table 83. Novartis Recent Development
Table 84. Kiadis Pharma Company Details
Table 85. Kiadis Pharma Business Overview
Table 86. Kiadis Pharma Product
Table 87. Kiadis Pharma Revenue in Alpha Thalassemia Business (2015-2020) (Million US$)
Table 88. Kiadis Pharma Recent Development
Table 89. Acceleron Pharma Company Details
Table 90. Acceleron Pharma Business Overview
Table 91. Acceleron Pharma Product
Table 92. Acceleron Pharma Revenue in Alpha Thalassemia Business (2015-2020) (Million US$)
Table 93. Acceleron Pharma Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Alpha Thalassemia Market Share by Type: 2020 VS 2026
Figure 2. Iron Chelating Drugs Features
Figure 3. Gene Therapy Features
Figure 4. Global Alpha Thalassemia Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Private clinics Case Studies
Figure 7. Other Case Studies
Figure 8. Alpha Thalassemia Report Years Considered
Figure 9. Global Alpha Thalassemia Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Alpha Thalassemia Market Share by Regions: 2020 VS 2026
Figure 11. Global Alpha Thalassemia Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Alpha Thalassemia Market Share by Players in 2019
Figure 14. Global Top Alpha Thalassemia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alpha Thalassemia as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Alpha Thalassemia Revenue in 2019
Figure 16. North America Alpha Thalassemia Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Alpha Thalassemia Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Alpha Thalassemia Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Alpha Thalassemia Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Alpha Thalassemia Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Alpha Thalassemia Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Alpha Thalassemia Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bluebird Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Bluebird Bio Revenue Growth Rate in Alpha Thalassemia Business (2015-2020)
Figure 25. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Novartis Revenue Growth Rate in Alpha Thalassemia Business (2015-2020)
Figure 27. Kiadis Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Kiadis Pharma Revenue Growth Rate in Alpha Thalassemia Business (2015-2020)
Figure 29. Acceleron Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Acceleron Pharma Revenue Growth Rate in Alpha Thalassemia Business (2015-2020)
Figure 31. Bottom-up and Top-down Approaches for This Report
Figure 32. Data Triangulation
Figure 33. Key Executives Interviewed